Skip to main content
Dryad

Data from: Sepiolite reinforced alginate-based hydrogels for drug delivery applications

Abstract

Cephradine (CD) is a first-generation bactericidal cephalosporin widely used for the treatment of urinary, respiratory, and skin infections. However, when it is taken directly, 8-17% of this drug binds to the serum, while almost 83-92% of this drug is released via the urinary tract without producing therapeutic action. On the other hand, alginate-based hydrogels demonstrated lower stabilities and lesser drug loading efficacy. Consequently, in the present work, we have prepared sepiolite (SEP) reinforced sodium alginate (SA)/poly(ethylene glycol) (PEG) hydrogels cross-linked with 3-aminopropyl(triethoxy)silane (APTS) crosslinker. The fabricated hydrogels were characterized by Fourier transform infrared spectroscopy (FTIR) and thermal gravimetric analysis (TGA), which confirmed the development of hydrogel interfaces. Hydrogels exhibited good swelling capability in distilled water that obeyed a non-Fickian diffusion process. The maximum swelling was exhibited at pH 8 in buffer and non-buffer solutions. In addition, the swelling abilities of hydrogels decreased by the increase in the amount of APTS. Biodegradation test confirmed their degradable nature up to 7 days. In 7 h, 81.32% of the CD was released and determined by UV-Visible spectrophotometer. The biodegradable and pH-responsive SA/PEG/SEP hydrogel platform could be a valuable choice for sustained delivery of drugs to deal with urinary and lower gastrointestinal infections.